Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.97 |
| ▸ | MEN1 | O00255 | 1/20 | 0.97 |
| ▸ | NPC1 | O15118 | 1/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.97 |
| ▸ | LMNA | P02545 | 1/20 | 0.97 |
| ▸ | GAA | P10253 | 1/20 | 0.97 |
| ▸ | MAPT | P10636 | 1/20 | 0.97 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.97 |
| ▸ | HTT | P42858 | 1/20 | 0.97 |
| ▸ | RAB9A | P51151 | 1/20 | 0.97 |
| ▸ | RUNX1 | Q01196 | 1/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.97 |
| ▸ | CBFB | Q13951 | 1/20 | 0.97 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.97 |
| ▸ | INMT | O95050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13416790 | 1.00 | FURIN (1.00) | FURINKDM4EMEN1NPC1ALDH1A1 | |
| SCHEMBL12611377 | 1.00 | FURIN (1.00) | FURINKDM4EMEN1NPC1ALDH1A1 | |
| Iodide SCHEMBL7704712 | 0.99 | KDM4E (1.00) | FURINKDM4EMEN1NPC1ALDH1A1 | |
| Iodide SCHEMBL7704714 | 0.99 | KDM4E (1.00) | FURINKDM4EMEN1NPC1ALDH1A1 | |
| SCHEMBL14116777 | 0.82 | FURIN (0.70) | FURINKDM4EMEN1NPC1ALDH1A1 | |
| SCHEMBL13416789 | 0.82 | FURIN (0.70) | FURINKDM4EMEN1NPC1ALDH1A1 | |
| SCHEMBL14465590 | 0.78 | FURIN (0.64) | FURINKDM4EMEN1NPC1ALDH1A1 | |
| SCHEMBL13416820 | 0.76 | FURIN (0.61) | FURINKDM4EMEN1NPC1ALDH1A1 | |
| SCHEMBL13416564 | 0.75 | FURIN (0.60) | FURINKDM4EMEN1NPC1ALDH1A1 | |
| SCHEMBL14184792 | 0.67 | FURIN (0.50) | FURINKDM4EMEN1NPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120035187-A1 | ANTI-NEURODEGENERATIVE DISEASE AGENT | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2012-02-09 | — | — | US | disclosed |
| US-7285375-B2 | Photosensitive composition, photosensitive lithography plate and method for producing lithography plate | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-10-23 | — | — | US | disclosed |
| US-7169535-B2 | Photosensitive composition and photosensitive lithographic printing plate | KONICA MINOLTA HOLDINGS, INC. (JP) | 2007-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035187-A1 | ANTI-NEURODEGENERATIVE DISEASE AGENT | SNCA, PSEN1, CDR2 | FURIN 3901/4885KDM4E 3242/4885MEN1 2218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.